Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes

mBio

Volumn 6, Issue 2, 2015, Pages 1-14

  Soong, Grace ^a   Paulino, Franklin ^a   Wachtel, Sarah ^a   Parker, Dane ^a   Wickersham, Matthew ^a   Zhang, Dongni ^a   Brown, Armand ^a   Lauren, Christine ^b   Dowd, Margaret ^a   West, Emily ^a   Horst, Basil ^b   Planet, Paul ^a   Prince, Alice ^a  

^a Department of Pediatricsa and Department of Dermatology Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 8; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; WORTMANNIN; AGR PROTEIN, STAPHYLOCOCCUS AUREUS; BACTERIAL PROTEIN; BACTERIAL TOXIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; AUTOPHAGY; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BIOACCUMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PYROPTOSIS; ADAPTATION; ANIMAL; DEFICIENCY; IMMUNE EVASION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ADAPTATION, BIOLOGICAL; ANIMALS; AUTOPHAGY; BACTERIAL PROTEINS; BACTERIAL TOXINS; HUMANS; IMMUNE EVASION; KERATINOCYTES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; TRANS-ACTIVATORS;

EID: 84928798972     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00289-15     Document Type: Article

References (66)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771. http://dx.doi.org/10.1001/jama.298.15.1763.
2. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, Moran GJ, EMERGEncy ID Net Study Group. 2011. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis 53: 144–149. http://dx.doi.org/10.1093/cid/cir308.
3. De Leo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557–1568. http://dx.doi.org/10.1016/S0140-6736(09)61999-1.
4. Heath W, Carbone F. 2013. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 14:978–985. http://dx.doi.org/10.1038/ni.2680.
5. Brown ML, O’Hara FP, Close NM, Mera RM, Miller LA, Suaya JA, Amrine-Madsen H. 2012. Prevalence and sequence variation of Panton-Valentine leukocidin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the United States. J Clin Microbiol 50: 86–90. http://dx.doi.org/10.1128/JCM.05564-11.
6. Singer AJ, Talan DA. 2014. Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus. NEngl J Med 370:1039–1047. http://dx.doi.org/10.1056/NEJMra1212788.
7. Lippens S, Denecker G, Ovaere P, Vandenabeele P, Declercq W. 2005. Death penalty for keratinocytes: apoptosis versus cornification. Cell Death Differ 12(Suppl 2):1497–1508. http://dx.doi.org/10.1038/sj.cdd.4401722.
8. Soong G, Chun J, Parker D, Prince A. 2012. Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis 205:1571–1579. http://dx.doi.org/10.1093/infdis/jis244.
9. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-Tekippe E, Ting JP, Duncan JA. 2009. Staphylococcus aureus alphahemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PloS One 4:e7446. http://dx.doi.org/10.1371/journal.pone.0007446.
10. Munoz-Planillo R, Franchi L, Miller LS, Nunez G. 2009. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureusinduced activation of the Nlrp3 inflammasome. J Immunol 183: 3942–3948. http://dx.doi.org/10.4049/jimmunol.0900729.
11. Chi CY, Lin CC, Liao IC, Yao YC, Shen FC, Liu CC, Lin CF. 2014. Panton-Valentine leukocidin facilitates the escape of Staphylococcus aureus from human keratinocyte endosomes and induces apoptosis. J Infect Dis 209:224–235. http://dx.doi.org/10.1093/infdis/jit445.
12. DuMont AL, Torres VJ. 2014. Cell targeting by the Staphylococcus aureus pore-forming toxins: it’s not just about lipids. Trends Microbiol 22:21–27. http://dx.doi.org/10.1016/j.tim.2013.10.004.
13. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M, Otto M. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 32:150–158. http://dx.doi.org/10.1016/j.molcel.2008.08.005.
14. Krishna S, Miller LS. 2012. Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin Immunopathol 34: 261–280. http://dx.doi.org/10.1007/s00281-011-0292-6.
15. Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL, Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI, Miller LS. 2012. Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog 8:e1003047. http://dx.doi.org/10.1371/journal.ppat.1003047.
16. Fitzgerald JR. 2014. Evolution of Staphylococcus aureus during human colonization and infection. Infect Genet Evol 21:542–547. http://dx.doi.org/10.1016/j.meegid.2013.04.020.
17. Planet PJ, LaRussa SJ, Dana A, Smith H, Xu A, Ryan C, Uhlemann AC, Boundy S, Goldberg J, Narechania A, Kulkarni R, Ratner AJ, Geoghegan JA, Kolokotronis SO, Prince A. 2013. Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speGmediated adaptations for survival on skin. mBio 4(6):e00889-13. http://dx.doi.org/10.1128/mBio.00889-13.
18. Aymard E, Barruche V, Naves T, Bordes S, Closs B, Verdier M, Ratinaud M-H. 2011. Autophagy in human keratinocytes: an early step of the differentiation? Exp Dermatol 20:263–268. http://dx.doi.org/10.1111/j.1600-0625.2010.01157.x.
19. Deretic V. 2012. Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24:21–31. http://dx.doi.org/10.1016/j.coi.2011.10.006.
20. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and inflammation. Nature 469:323–335. http://dx.doi.org/10.1038/nature09782.
21. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, Kehrl JH. 2012. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13:255–263. http://dx.doi.org/10.1038/ni.2215.
22. Boguniewicz M, Leung DY. 2011. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233–246. http://dx.doi.org/10.1111/j.1600-065X.2011.01027.x.
23. Shopsin B, Drlica-Wagner A, Mathema B, Adhikari R, Kreiswirth B, Novick R. 2008. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis 198:1171–1175. http://dx.doi.org/10.1086/592051.
24. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, Hasegawa M, Villaruz AE, Cheung GY, McGavin MJ, Travers JB, Otto M, Inohara N, Nunez G. 2013. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature 503:397–401. http://dx.doi.org/10.1038/nature12655.
25. Valour F, Rasigade JP, Trouillet-Assant S, Gagnaire J, Bouaziz A, Karsenty J, Lacour C, Bes M, Lustig S, Benet T, Chidiac C, Etienne J, Vandenesch F, Ferry T, Laurent F, Lyon BJI Study Group. 10 February 2015. Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation. Clin Microbiol Infect http://dx.doi.org/10.1016/j.cmi.2015.01.026.
26. Cheung GY, Duong AC, Otto M. 2012. Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes Infect 14:380–386. http://dx.doi.org/10.1016/j.micinf.2011.11.013.
27. Otto M. 2014. Staphylococcus aureus toxins. Curr Opin Microbiol 17: 32–37. http://dx.doi.org/10.1016/j.mib.2013.11.004.
28. Date SV, Modrusan Z, Lawrence M, Morisaki JH, Toy K, Shah IM, Kim J, Park S, Xu M, Basuino L, Chan L, Zeitschel D, Chambers HF, Tan MW, Brown EJ, Diep BA, Hazenbos WL. 2014. Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infection. J Infect Dis 209:1542–1550. http://dx.doi.org/10.1093/infdis/jit668.
29. Ingham KC, Brew S, Vaz D, Sauder DN, McGavin MJ. 2004. Interaction of Staphylococcus aureus fibronectin-binding protein with fibronectin: affinity, stoichiometry, and modular requirements. J Biol Chem 279: 42945–42953. http://dx.doi.org/10.1074/jbc.M406984200.
30. Grosz M, Kolter J, Paprotka K, Winkler AC, Schafer D, Chatterjee SS, Geiger T, Wolz C, Ohlsen K, Otto M, Rudel T, Sinha B, Fraunholz M. 2014. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell Microbiol 16:451–465. http://dx.doi.org/10.1111/cmi.12233.
31. Cole J, Aberdein J, Jubrail J, Dockrell DH. 2014. The role of macrophages in the innate immune response to Streptococcus pneumoniae and Staphylococcus aureus: mechanisms and contrasts. Adv Microb Physiol 65:125–202. http://dx.doi.org/10.1016/bs.ampbs.2014.08.004.
32. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A. 2010. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11:1136–1142. http://dx.doi.org/10.1038/ni.1960.
33. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. 2014. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 15:135–147. http://dx.doi.org/10.1038/nrm3737.
34. Mizushima N, Yoshimori T, Levine B. 2010. Methods in mammalian autophagy research. Cell 140:313–326. http://dx.doi.org/10.1016/j.cell.2010.01.028.
35. Deretic V. 2012. Autophagy: an emerging immunological paradigm. J Immunol 189:15–35. http://dx.doi.org/10.4049/jimmunol.1102108.
36. Kloft N, Neukirch C, Bobkiewicz W, Veerachato G, Busch T, von Hoven G, Boller K, Husmann M. 2010. Pro-autophagic signal induction by bacterial pore-forming toxins. Med Microbiol Immunol 199:299–608. http://dx.doi.org/10.1007/s00430-010-0163-0.
37. Ku CC, Besser J, Abendroth A, Grose C, Arvin AM. 2005. Varicellazoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol 79:2651–2658. http://dx.doi.org/10.1128/JVI.79.5.2651-2658.2005.
38. Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. 2012. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482:414–418. http://dx.doi.org/10.1038/nature10744.
39. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, Ong CN, Codogno P, Shen HM. 2010. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 285:10850–10861. http://dx.doi.org/10.1074/jbc.M109.080796.
40. Warnes G. 2014. Measurement of autophagy by flow cytometry. Curr Protoc Cytom 68:9451–94510. http://dx.doi.org/10.1002/0471142956.cy0945s68.
41. Amano A, Nakagawa I, Yoshimori T. 2006. Autophagy in innate immunity against intracellular bacteria. J Biochem 140:161–167. http://dx.doi.org/10.1093/jb/mvj162.
42. Byrne BG, Dubuisson JF, Joshi AD, Persson JJ, Swanson MS. 2013. Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection. mBio 4(1):e00620-12. http://dx.doi.org/10.1128/mBio.00620-12.
43. Lee H-M, Shin D-M, Yuk J-M, Shi G, Choi D-K, Lee S-H, Huang S, Kim J-M, Kim C, Lee J-H, Jo E-K. 2011. Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62/SQSTM 1. J Immunol 186:1248–1306. http://dx.doi.org/10.4049/jimmunol.1001954.
44. Miller LS, Cho JS. 2011. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 11:505–518. http://dx.doi.org/10.1038/nri3010.
45. Deshmukh H, Hamburger J, Ahn S, McCafferty D, Yang S, Fowler V. 2009. Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect Immun 77:1376–1458. http://dx.doi.org/10.1128/IAI.00940-08.
46. Ulland TK, Ferguson PJ, Sutterwala FS. 2015. Evasion of inflammasome activation by microbial pathogens. J Clin Invest 125:469–477. http://dx.doi.org/10.1172/JCI75254.
47. Nauseef WM. 2007. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219:88–102. http://dx.doi.org/10.1111/j.1600-065X.2007.00550.x.
48. Jarry TM, Memmi G, Cheung AL. 2008. The expression of alphahaemolysin is required for Staphylococcus aureus phagosomal escape after internalization in CFT-1 cells. Cell Microbiol 10:1801–1814. http://dx.doi.org/10.1111/j.1462-5822.2008.01166.x.
49. Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, Jr, Fabry ME, Skaar EP. 2010. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8:544–550. http://dx.doi.org/10.1016/j.chom.2010.11.002.
50. Berube BJ, Sampedro GR, Otto M, Bubeck Wardenburg J. 2014. The psma locus regulates production of Staphylococcus aureus alpha-toxin during infection. Infect Immun 82:3350–3358. http://dx.doi.org/10.1128/IAI.00089-14.
51. Sampedro GR, DeDent AC, Becker RE, Berube BJ, Gebhardt MJ, Cao H, Bubeck Wardenburg J. 2014. Targeting Staphylococcus aureus alphatoxin as a novel approach to reduce severity of recurrent skin and softtissue infections. J Infect Dis 210:1012–1018. http://dx.doi.org/10.1093/infdis/jiu223.
52. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164:3713–3722. http://dx.doi.org/10.4049/jimmunol.164.7.3713.
53. Hamza T, Li B. 2014. Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection. BMC Microbiol 14:207. http://dx.doi.org/10.1186/s12866-014-0207-5.
54. Svider PF, Husain Q, Mauro KM, Folbe AJ, Baredes S, Eloy JA. 2014. Impact of mentoring medical students on scholarly productivity. Int Forum Allergy Rhinol 4:138–142. http://dx.doi.org/10.1002/alr.21247.
55. Golubchik T, Batty EM, Miller RR, Farr H, Young BC, Larner-Svensson H, Fung R, Godwin H, Knox K, Votintseva A, Everitt RG, Street T, Cule M, Ip CL, Didelot X, Peto TE, Harding RM, Wilson DJ, Crook DW, Bowden R. 2013. Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PloS One 8:e61319. http://dx.doi.org/10.1371/journal.pone.0061319.
56. Slingerland BC, Tavakol M, McCarthy AJ, Lindsay JA, Snijders SV, Wagenaar JA, van Belkum A, Vos MC, Verbrugh HA, van Wamel WJ. 2012. Survival of Staphylococcus aureus ST398 in the human nose after artificial inoculation. PloS One 7:e48896. http://dx.doi.org/10.1371/journal.pone.0048896.
57. Shopsin B, Eaton C, Wasserman GA, Mathema B, Adhikari RP, Agolory S, Altman DR, Holzman RS, Kreiswirth BN, Novick RP. 2010. Mutations in agr do not persist in natural populations of methicillin-resistant Staphylococcus aureus. J Infect Dis 202:1593–1599. http://dx.doi.org/10.1086/656915.
58. Smyth DS, Kafer JM, Wasserman GA, Velickovic L, Mathema B, Holzman RS, Knipe TA, Becker K, von Eiff C, Peters G, Chen L, Kreiswirth BN, Novick RP, Shopsin B. 2012. Nasal carriage as a source of agrdefective Staphylococcus aureus bacteremia. J Infect Dis 206:1168–1177. http://dx.doi.org/10.1093/infdis/jis483.
59. Garbacz K, Piechowicz L, Baranska-Rybak W, Dabrowska-Szponar M. 2011. Staphylococcus aureus isolated from patients with recurrent furunculosis carrying Panton-Valentine leukocidin genes represent agr specificity group IV. Eur J Dermatol 21:43–46. http://dx.doi.org/10.1684/ejd.2010.1151.
60. Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR, Nauseef WM. 2010. agr-dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2:546–559. http://dx.doi.org/10.1159/000319855.
61. Sully EK, Malachowa N, Elmore BO, Alexander SM, Femling JK, Gray BM, DeLeo FR, Otto M, Cheung AL, Edwards BS, Sklar LA, Horswill AR, Hall PR, Gresham HD. 2014. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PloS Pathog 10:e1004174. http://dx.doi.org/10.1371/journal.ppat.1004174.
62. Martin FJ, Gomez MI, Wetzel DM, Memmi G, O’Seaghdha M, Soong G, Schindler C, Prince A. 2009. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 119:1931–1939. http://dx.doi.org/10.1172/JCI35879.
63. Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML, Staeheli P, Wack A. 2013. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog 9:e1003773. http://dx.doi.org/10.1371/journal.ppat.1003773.
64. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194:1761–1770. http://dx.doi.org/10.1086/509506.
65. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510–1514. http://dx.doi.org/10.1038/nm1656.
66. Pearson T, Greiner DL, Shultz LD. 2008. Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol 324:25–51. http://dx.doi.org/10.1007/978-3-540-75647-7_2.